压力感受性反射激活疗法治疗心力衰竭的研究进展  

Baroreflex Activation Therapy for Heart Failure

作　　者：徐奕 杨跃进[2] 郭军 XU Yi;YANG Yuejin;GUO Jun(Department of Cardiology,The First Affiliated Hospital of Jinan University,Guangzhou 510630,China;Department of Cardiology,Fuwai Hospital,CAMS and PUMC,Beijing 100037,China)

机构地区：[1]暨南大学附属第一医院广州华侨医院心血管内科,广州510630 [2]中国医学科学院北京协和医学院阜外医院冠心病中心,北京100037

出　　处：《中国医学科学院学报》2022年第4期717-721,共5页Acta Academiae Medicinae Sinicae

摘　　要：心力衰竭(HF)是多种心血管疾病终末阶段的共同表现,自主神经功能调节受损、交感-副交感失衡是其进展的重要因素。近年来研究表明,压力感受性反射激活疗法(BAT)通过植入设备发放电刺激颈动脉窦压力感受器,增强副交感系统兴奋性,抑制交感系统兴奋性,对HF起到治疗作用,改善患者预后。本文试对BAT治疗HF的相关研究及进展进行归纳与总结,并对其优势及应用前景进行综述与展望。Heart failure(HF) is the endstage of multiple cardiovascular diseases.Impaired autonomic regulation and sympathetic-parasympathetic imbalance are considered key factors in HF progression.Baroreflex activation therapy(BAT),a novel device-based therapy which stimulates the carotid sinuses and regulates autonomic function, has demonstrated good efficacy in treating HF and improving prognosis.This review summarized the results of the latest relevant studies to provide support for further study of BAT.

关 键 词：心力衰竭 压力感受性反射激活疗法 自主神经 器械治疗 

分 类 号：R541.6[医药卫生—心血管疾病] R459.9[医药卫生—内科学]